U.S. Software Stock News

NYSE:CRGY
NYSE:CRGYOil and Gas

Did Repeated Earnings Beats and a Positive ESP Just Shift Crescent Energy's (CRGY) Investment Narrative?

Recently, Crescent Energy’s earnings reports have come in well ahead of analyst expectations, with the company outperforming consensus estimates by an average of very large in the last two quarters. With a positive Zacks Earnings ESP and a Zacks Rank #3 (Hold), recent analyst commentary points to growing confidence that Crescent Energy could once again exceed near-term earnings expectations. Next, we’ll examine how this pattern of recent earnings outperformance and a positive Earnings ESP...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is Intel (INTC) Undervalued On Its AI Classroom Push Or Already Fully Valued?

Intel (INTC) is back in focus after joining ASUS Education at ISTE+ASCD 2026 in Orlando, highlighting a wide range of AI ready, classroom focused devices built on Intel platforms. See our latest analysis for Intel. For investors, Intel’s presence at ISTE+ASCD comes after a sharp pullback in the share price, which fell 9.66% over the past day and 20.94% over the past week. Despite this, it still shows an 11.31% 1 month share price return, an 87.26% 3 month share price return and a very large 1...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Stock May Be Cheap As Its AI Deal Expands

Adobe stock has had a tough run over the past five years, yet current valuation checks suggest the market may now be pricing it more cautiously than the fundamentals alone would indicate. Adobe shareholders have seen the stock decline 63.6% over 5 years, which puts added focus on whether the current price reflects overly pessimistic expectations. On the upside, Adobe's push to deepen its AI capabilities through deals like the planned Topaz Labs acquisition and new tools such as Firefly...
NYSE:DHT
NYSE:DHTOil and Gas

3 High Yield US Stocks Built For Steady Income

Global inflation worries, higher bond yields and volatile energy prices are pushing many investors to look for income that feels more resilient than cash or broad equity markets. That is where the Dividend Fortresses screener comes in, focusing on stocks that combine a 5%+ dividend yield with characteristics that can help support payouts through economic ups and downs. In this article, three of the stocks from the Dividend Fortresses list are highlighted, so you can see how this theme may fit...
NasdaqGS:IQMX
NasdaqGS:IQMXTech

IQM Quantum Computers (NasdaqGS:IQMX) Stock Still Looks Pricey Following Quantistry Asset Deal

IQM Quantum Computers Oyj stock has slipped around 1.1% year to date, and with a low overall value score the market is signaling that this quantum computing story is not an obvious bargain at its recent €12.89 close. The share price is down about 1.1% year to date, which points to a cautious start for IQM Quantum Computers Oyj as it moves toward broader public listings. The acquisition of Quantistry GmbH’s assets can support expectations for richer quantum solutions in industrial sectors. At...
NYSE:IEX
NYSE:IEXMachinery

IDEX (IEX) Stock May Be 22% Undervalued On Cash Flow Strength

IDEX stock is up 23.5% year to date, yet there is a clear split between what the Discounted Cash Flow (DCF) intrinsic value suggests and what traditional market multiples say, with the stock screening undervalued on the DCF view but overvalued on earnings based ratios. That gap, alongside a mixed overall value score, puts the current US$221.07 share price under closer scrutiny. Year to date, IDEX has returned 23.5%, which puts recent price strength front and centre in any valuation...
NYSE:LEU
NYSE:LEUOil and Gas

Centrus Energy (LEU) Joins S&P SmallCap 600 After Recent Russell Index Exits

Centrus Energy (NYSE:LEU) is set to join the S&P SmallCap 600 Index on July 14, 2026. The inclusion follows the company’s recent removal from multiple Russell indexes only weeks earlier. The move highlights renewed acknowledgment of Centrus Energy’s role in U.S. nuclear fuel security and uranium enrichment. Centrus Energy, a supplier of nuclear fuel and related services, sits at the center of U.S. efforts to rebuild domestic uranium enrichment capabilities. As governments and utilities...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Stock Looks Pricey After New Obesity Trial Launch

Viking Therapeutics has delivered a very large 5 year return, yet its current checks lean expensive, which raises questions about how much of the obesity drug opportunity is already reflected in the stock price. Viking Therapeutics has returned about 6x over 5 years, which puts extra focus on whether recent gains leave limited room for disappointment. The launch of the Phase 1 trial for obesity candidate VK3019 can support expectations for a broader weight loss pipeline. At the same time,...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Stock Still Looks Below Fair Value Despite Rich Earnings

Eli Lilly stock has surged over the past few years, and at around US$1,235 per share today, investors face a clear tension between strong price momentum and mixed valuation signals. The Discounted Cash Flow (DCF) intrinsic value suggests upside, while market multiples look rich. Eli Lilly has delivered a very large 5 year return of about 4.5x, which puts extra focus on whether the current price still leaves any margin of safety. Expectations around continued demand for Eli Lilly's obesity...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

SELLAS Life Sciences Group (SLS) Draws Fresh Attention, Is The Premium Already Priced In?

SELLAS Life Sciences Group (SLS) is back in focus after MassMutual disclosed a small new stake ahead of the company’s key Phase 3 REGAL AML trial readout, which investors view as a major catalyst. See our latest analysis for SELLAS Life Sciences Group. Despite a pullback with a 1 day share price return of down 3.16% and a 7 day share price return of down 8.54%, SELLAS Life Sciences Group still reflects strong momentum with a 30 day share price return of 64.03% and a year to date share price...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Ocular Therapeutix (OCUL) Joins Russell Value Indexes, Is The Stock Now Too Pricey?

Ocular Therapeutix (OCUL) was added to several Russell value and small cap benchmarks on June 27, 2026, a change that can influence trading activity as index trackers adjust their holdings. See our latest analysis for Ocular Therapeutix. The Russell index additions come after a sharp recent rebound in Ocular Therapeutix, with a 30 day share price return of 26.59% and a 90 day share price return of 11.08%, even though the year to date share price return is still down 12.61% and the 1 year...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

LPL Financial (LPLA) Wins A $6 Billion Advisor Team And Expands Its Network

LPL Financial Holdings (NasdaqGS:LPLA) is reporting fresh advisor movement, including a $6 billion advisor team transition connected to Commonwealth and LPL Financial into a new hybrid RIA. The firm is adding experienced talent such as advisor David Logsdon, who oversees substantial client assets, to its independent advisor network. LPL Financial is also seeing new independent practices launch on its platform, including Haskin Private Wealth Advisors. LPL Financial sits at the center of the...
NasdaqGS:CNXN
NasdaqGS:CNXNElectronic

PC Connection (CNXN) Stock Looks Fairly Valued As Its 81% Five Year Run Continues

PC Connection stock has delivered an 81.3% total return over the past 5 years. With the shares recently closing at US$74.30, the current checks suggest it no longer looks obviously cheap or clearly expensive. Instead, the valuation picture sits in the middle, with recent gains set against an overall verdict that the stock is priced roughly in line with its fundamentals. Over 5 years, a total return of 81.3% indicates PC Connection has rewarded patient shareholders, which raises the bar for...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Columbia Banking System (COLB) Stock Looks Fairly Valued After An 83% Run

Columbia Banking System’s stock has put in a strong 3 year run, yet on current checks it looks closer to fairly priced than like a clear bargain, leaving investors weighing past gains against what the valuation signals now suggest. Over the past 3 years, Columbia Banking System has returned 82.8%, which puts added focus on whether the current share price already reflects much of that progress. For a regional bank, the key support for valuation can come from steady loan growth and consistent...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

Amkor Technology (AMKR) Stock May Be Undervalued After Arizona AI Packaging Deal

Amkor Technology stock has delivered a very strong 205.4% total return over the past five years, yet on Simply Wall St’s valuation checks it still screens as attractively priced rather than fully stretched. Over five years, Amkor Technology has returned 205.4%, which puts recent share price weakness into the context of a strong longer term run. The long term partnership with TSMC around advanced AI chip packaging can support expectations for higher value work. At the same time, recent...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Does Kaiser Aluminum’s (KALU) Index Shift Recast Its Core Narrative as a Defensive Compounder?

On 27 June 2026, Kaiser Aluminum Corporation was removed from several Russell value benchmarks but added to the Russell 2000 Defensive and Growth-Defensive indices, reflecting a reshuffle in how the stock is classified across these benchmarks. This mix of index deletions and additions may shift how both value-oriented and defensively focused investors gain exposure to Kaiser Aluminum through index-linked products. Next, we'll consider how Kaiser Aluminum’s move from Russell value benchmarks...
NasdaqGS:SHBI
NasdaqGS:SHBIBanks

Undervalued Small Caps With Insider Activity To Explore In July 2026

In the last week, the United States market has stayed flat, yet it has seen a 20% increase over the past year with earnings forecasted to grow by 18% annually. In this dynamic environment, identifying small-cap stocks that are potentially undervalued and exhibit insider activity can be a promising strategy for investors looking to explore opportunities in July 2026.
NasdaqCM:DGXX
NasdaqCM:DGXXSoftware

US High Growth Tech Stocks To Watch

In the last week, the market has stayed flat, but it is up 20% over the past year with earnings forecast to grow by 18% annually. In such an environment, identifying high growth tech stocks that align with these positive trends can be crucial for investors seeking to capitalize on potential opportunities in the United States.
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Discovering 3 Stocks That Might Be Priced Below Their Estimated Intrinsic Value

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has risen by an impressive 20%, with earnings forecasted to grow by 18% annually. In this context of steady growth and positive earnings outlooks, identifying stocks that might be priced below their estimated intrinsic value can present potential opportunities for investors seeking to capitalize on market inefficiencies.
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development

Certara has announced a partnership with NVIDIA to enhance its AI platform for drug discovery and development by incorporating the NVIDIA BioNeMo Agent Toolkit. This collaboration aims to unify Certara's biosimulation software, regulatory expertise, and datasets with AI-driven agents that provide specialized insights for life sciences. The toolkit enables AI agents to function autonomously, complementing biosimulation models and scientific expertise to accelerate the drug development process...
NasdaqCM:CXDO
NasdaqCM:CXDOIT

3 Promising Growth Companies With Insider Ownership Up To 35%

The United States market remained flat over the last week but has experienced a 20% increase over the past year, with earnings forecast to grow by 18% annually. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business.
NasdaqCM:TVRD
NasdaqCM:TVRDPharmaceuticals

Top Penny Stocks To Watch In July 2026

In the last week, the market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. For those looking to invest in smaller or newer companies, penny stocks — despite being a somewhat outdated term — can still offer surprising value. In this article, we spotlight several penny stocks that stand out for their financial strength and potential for long-term success amidst current market conditions.
NasdaqGS:CME
NasdaqGS:CMECapital Markets

Top Dividend Stocks To Consider In July 2026

In the last week, the United States market has stayed flat, but over the past 12 months, it has seen a notable rise of 20%, with earnings expected to grow by 18% annually in the coming years. In such an environment, dividend stocks that offer consistent income and potential for capital appreciation can be appealing options for investors seeking stability and growth.